Fact checked byMindy Valcarcel, MS

Read more

December 27, 2022
1 min read
Save

Cancer immunologist to present AACR-Irving Weinstein Foundation Distinguished Lectureship

Fact checked byMindy Valcarcel, MS
You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Andrea Schietinger, PhD, will present the 19th AACR-Irving Weinstein Foundation Distinguished Lectureship during the American Association for Cancer Research Annual Meeting, which will be held April 14-19 in Florida.

The lectureship acknowledges individuals whose outstanding personal innovation in science and whose position in their respective field relevant to cancer research has the potential to inspire creative thinking and new directions in cancer research.

Infographic with quote from Lisa M. Coussens, PhD, FAACR

Schietinger will be recognized scientific contributions to the field of immunology.

Schietinger is associate member of the immunology program at Memorial Sloan Kettering Cancer Center, as well as associate professor of immunology and microbial pathogenesis at Weill Cornell Medical College.

Andrea Schietinger, PhD
Andrea Schietinger

“I am thrilled that Dr. Schietinger is the 2023 Weinstein Foundation lecturer,” Lisa M. Coussens, PhD, FAACR, president of the AACR, said in a press release. “As a classically trained immunologist, Dr. Schietinger brings to tumor immunology remarkable insights into T-cell functionality that are sure to impact strategies for immune therapy in patients with cancer.”

Schietinger’s research has advanced the medical community’s understanding of molecular mechanisms of T-cell function and immune responses to disease. Her research also has furthered understanding of the cellular mechanisms by which antigen-specific T cells evade immune-suppressive mechanisms in normal tissue and tumor ecosystems, according to the release.